Low Affinity Sodium Glucose Cotransporter (SGLT2):阻害薬のグローバル市場2015(薬開発、治験動向)

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIMRMOA5431)
◆英語タイトル:Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors -Pipeline Insights, 2015
◆発行会社/調査会社:DelveInsight
◆商品コード:DIMRMOA5431
◆発行日:2015年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:25以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥136,250見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥272,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[Low Affinity Sodium Glucose Cotransporter (SGLT2):阻害薬のグローバル市場2015(薬開発、治験動向)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

DelveInsight’s,“Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors -Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors . This report provides information on the therapeutic development based on the Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors dealing with mechanism of action, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

[Data Sources]

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated mechanism of action.


• The report provides a snapshot of the global therapeutic landscape of Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

*** レポート目次(コンテンツ)***

• Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors Overview
• Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors Disease Associated
• Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors Pipeline Therapeutics
• Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors Therapeutics under Development by Companies
• Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors Late Stage Products (Filed and Phase III)
• Comparative Analysis
• Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors Mid Clinical Stage Products (Phase II)
• Comparative Analysis
• Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors Early Clinical Stage Products (Phase I and IND Filed)
• Comparative Analysis
• Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors Discovery and Pre-Clinical Stage Products
• Comparative Analysis
• Drug Candidate Profiles
• Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors – Therapeutics Assessment
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors – Discontinued Products
• Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors – Dormant Products
• Companies Involved in Therapeutics Development for Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors
• Appendix
• Methodology
• Contact Us
• Disclaimer

• Number of Products under Development for Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors by Therapy Area, 2015
• Number of Products under Development for Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors , 2015
• Number of Products under Development by Companies
• Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2015
• Comparative Analysis Mid Clinical Stage Products (Phase II), 2015
• Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2015
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2015
• Drug Candidates Profiles
• Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors Assessment by Monotherapy Products
• Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors Assessment by Combination Products
• Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors Assessment by Route of Administration
• Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors Assessment by Stage and Route of Administration
• Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors Assessment by Molecule Type
• Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors Assessment by Stage and Molecule Type
• Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors Therapeutics – Discontinued Products
• Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors Therapeutics – Dormant Products
• Products under Development by Companies, 2015

• Number of Products under Development for Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors by Therapy Area, 2015
• Number of Products under Development for Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors , 2015
• Late Clinical Stage Products (Filed and Phase III), 2015
• Mid Clinical Stage Products (Phase II), 2015
• Early Clinical Stage Products (Phase I and IND Filed), 2015
• Discovery and Pre-Clinical Stage Products, 2015
• Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors Assessment by Monotherapy Products
• Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors Assessment by Combination Products
• Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors Assessment by Route of Administration
• Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors Assessment by Stage and Route of Administration
• Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors Assessment by Molecule Type
• Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors Assessment by Stage and Molecule Type

*** レポートのキーワード ***

薬剤、医薬品、製薬企業、試験、作用機序(MOA)、パイプライン、開発

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • キルギスの鉄製ローラー・チェーン市場(~2019)
    The industry report Steel and Iron Chain Market in Kyrgyzstan to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for steel and iron chains in Kyrgyzstan. The research includes historic market data from 2008 to 2 …
  • トリブロモエチレンの世界市場2019
    The Global Tribromoethylene (CAS 598-16-3) Industry 2019 Market Research Report is a professional and in-depth study on the current state of the Tribromoethylene industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry …
  • スペインのモバイル端末市場(~2015):通信技術別販売状況
    Summary "Spain Mobile Handset Market to 2015: Mobile Handset Sales by Technology and by Generation" report provides a top-level overview and detailed insights into the operating environment for mobile operators. It is an essential tool for companies active across the telecom value chain in Spain and …
  • Universal Potash Corp. (UTUC):企業SWOT分析(エネルギー業界)
    Summary This comprehensive SWOT profile of Universal Potash Corp. provides you with an in-depth strategic analysis of the company's businesses and operations. The profile will give you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and thre …
  • 世界のシリカゲル市場2016
    The Global Silica Gel Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Silica Gel industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Silica …
  • ソフトドリンク(飲料)市場(~2017):ギニア-Bissau
    Synopsis "Soft Drinks Market in Guinea-Bissau: Databook to 2017" is the result of Canadean’s extensive market research covering the Soft Drinks market in Guinea-Bissau. The report presents detailed historic and forecast data on the Soft Drinks consumption trends in Guinea-Bissau, offering consumptio …
  • Esperion Therapeutics, Inc. :企業製品パイプライン分析2013(ヘルスケア市場レポート)
    Esperion Therapeutics, Inc. - Product Pipeline Review - 2013 Summary Global Markets Direct’s pharmaceuticals report, “Esperion Therapeutics, Inc. - Product Pipeline Review - 2013” provides data on the Esperion Therapeutics, Inc.’s research and development focus. The report includes information on cu …
  • 輸血診断の世界市場予測2018-2023
    Intravenous transfer of blood or blood products is known as blood transfusion. Replacement of lost blood components can be done with the help of blood transfusion. Blood components like red blood cells, white blood cells, platelets, clotting factors and plasma are mostly transfused. These blood comp …
  • オマーンのソフトドリンク市場2015:市場動向、予測
    Summary Some of the key trends noted across Oman include: consumers starting to watch their sugar intake especially in western markets where low calorie variants are taking share, or consumers moving towards packaged water and flavoured waters; fruit powders continuing to fall across many of the mar …
  • 世界及び中国の1,3,5-トリメシン酸市場2018
    The 'Global and Chinese 1,3,5-Trimesic Acid Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global 1,3,5-Trimesic Acid industry with a focus on the Chinese market. The report provides key statistics on the market status of the 1,3,5-Trimes …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIMRMOA5431 )"Low Affinity Sodium Glucose Cotransporter (SGLT2):阻害薬のグローバル市場2015(薬開発、治験動向)" (英文:Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors -Pipeline Insights, 2015)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。